Clinical trial Recruiting at 1 site Observational Ages Any age to 17

Observational study on congenital diaphragmatic hernia in newborns and children

Official title: ECHO-CDH - Exploratory Observational Prospective Study in Neonatal and Pediatric Congenital Diaphragmatic Hernia

Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT04114578 · Data updated 2026-11-12

This study looks at how congenital diaphragmatic hernia affects the heart and lungs in newborns and children to see if they face ongoing health challenges as they grow up.

More Congenital Diaphragmatic Hernia trials

Quick facts

Study typeObservational
AgesAny age to 17 Years
SexAll
Enrollment80 (estimated)
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedOctober 1, 2019
Main results expectedDecember 31, 2023
Study endsJune 30, 2025
Registry record updatedNovember 22, 2024
Trial IDNCT04114578 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are newborns and children diagnosed with congenital diaphragmatic hernia who are either admitted to the NICU or followed in the outpatient clinic.

Probably not a fit

Patients who are premature (less than 36 weeks), diagnosed after 7 days of life, have bilateral CDH, or have significant congenital cardiac defects or genetic syndromes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the cardiac performance and pulmonary pressures in newborns and children with congenital diaphragmatic hernia (CDH). It will utilize advanced echocardiography techniques to assess left ventricular size and function, as well as pulmonary pressures, at various pediatric ages. The study will recruit CDH patients from the neonatal intensive care unit and follow-up clinics, synchronizing with existing follow-up programs for feasibility. The hypothesis is that CDH patients may continue to experience cardiac and pulmonary issues as they grow, which could lead to higher morbidity and altered neurodevelopmental outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of cardiac and pulmonary complications in CDH patients, potentially enhancing their long-term health outcomes.

How similar studies have gone: While this study employs novel echocardiography techniques, similar studies have shown that understanding cardiac performance in CDH patients can lead to better management strategies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion:

* CDH patients admitted to the MCH-NICU
* CDH followed at the MCH CDH clinic

Exclusion:

* Prematurity (\< 36 weeks)
* Diagnosis at \> 7 days of life
* Bilateral CDH
* Congenital cardiac defect (excluding a patent ductus arteriosus (PDA), atrial septal defect (ASD) or ventricular septal defect (VSD)) and/or other major anomaly/genetic syndrome.

Where it's running

  • Mcgill University Health Centre
    Montreal, Quebec, Canada
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.